Milestone Pharmaceuticals...

NASDAQ: MIST · Real-Time Price · USD
1.70
0.02 (1.19%)
At close: Aug 15, 2025, 3:59 PM
1.67
-1.47%
After-hours: Aug 15, 2025, 07:57 PM EDT

Milestone Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a -868K -868K -868K 132K 4.5M 6M 6M 5M 16.5M 15M 30M 30M 72.44M 72.44M 57.44M
Cost of Revenue
593K 621K 586K 610K 608K 580K 454K 10.26M 10.26M 10.28M 10.16M 363K 9.77M 9.77M 38.2M 46.4M 45.59M
Gross Profit
-26K -54K -1.45M -1.48M -1.48M -448K 4.05M -4.26M -4.26M -5.28M 6.34M 14.64M 20.23M 20.23M 34.25M 26.04M 11.85M
Operating Income
-52.15M -42.17M -43.7M -49.44M -56.21M -61.17M -61.06M -60.73M -61.1M -59.64M -62.8M -62.04M -44.53M -43.07M -34.92M -32.73M -46.55M
Interest Income
3.87M 4.16M 4.31M 4.35M 4.37M 3.96M 3.5M 2.85M 1.8M 1.25M 706K 280K 180K 220K 282K 323K 391K
Pretax Income
-31.23M -41.65M -42.91M -48.55M -55.23M -59.76M -59.25M -58.73M -59.33M -58.39M -62.09M -61.76M -44.35M -42.85M -34.63M -32.41M -46.16M
Net Income
-31.16M -41.52M -42.77M -48.41M -55.09M -59.69M -27.82M -26.82M -27.26M -26.28M -61.42M -61.57M -44.31M -42.85M -34.63M -32.39M -46.14M
Selling & General & Admin
26.05M 27.69M 27.63M 30.62M 31.61M 31.05M 29.38M 27.44M 25.78M 24.81M 24.13M 21.97M 20.68M 19.4M 16.4M 15.71M 15.34M
Research & Development
15.76M 14.49M 15.98M 18.74M 24.48M 31.03M 36.18M 39.28M 41.32M 39.83M 40.17M 40.07M 38.84M 38.67M 33.52M 32.02M 31.21M
Other Expenses
n/a n/a n/a n/a n/a n/a 48.92M 51.59M 51.59M 51.59M 48.34M 45.67M 47.52M 47.52M 1.84M 1.84M n/a
Operating Expenses
41.27M 41.64M 43.14M 48.88M 55.65M 61.64M 65.56M 66.73M 67.1M 64.64M 64.3M 62.04M 59.53M 58.07M 49.92M 47.73M 46.55M
Interest Expense
3.64M 3.58M 3.52M 3.46M 3.39M 2.55M 1.69M 853K 33K n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
8.12M 11M 11.57M 14.07M 15.64M 15.11M 12.7M 10.95M 9.81M 9.1M 8.75M 7.66M 7.27M 7M 6.11M 5.44M 5.12M
Cost & Expenses
31.63M 42.17M 43.7M 49.44M 56.21M 62.17M 65.56M 66.73M 67.1M 64.64M 64.3M 62.04M 59.53M 58.07M 49.92M 47.73M 46.55M
Income Tax Expense
-65K -133K -142K -142K -142K -74K -31.43M -31.91M -32.07M -32.11M -638K -164K -6K -57K -74K -91K -91K
Shares Outstanding (Basic)
66.29M 62.21M 66.19M 66.17M 50.16M 33.48M 42.97M 42.94M 42.85M 42.78M 42.49M 42.28M 42.24M 42.18M 42.19M 41.67M 41.26M
Shares Outstanding (Diluted)
66.29M 62.21M 66.19M 66.17M 50.16M 33.48M 42.97M 42.94M 42.85M 42.78M 42.49M 42.28M 42.24M 42.18M 42.19M 44.53M 41.26M
EPS (Basic)
-0.79 -0.69 -0.9 -1.11 -1.34 -1.48 -0.64 -0.62 -0.64 -0.62 -1.45 -1.46 -1.05 -1.02 -0.91 -0.97 -1.52
EPS (Diluted)
-0.79 -0.69 -0.9 -1.11 -1.34 -1.48 -0.64 -0.62 -0.64 -0.62 -1.45 -1.46 -1.05 -1.02 -0.91 -0.97 -1.52
EBITDA
-49.6M -38.59M -39.95M -44.63M -51.39M -56.77M -58.21M -58.44M -59.95M -59.08M -62.23M -61.95M -44.43M -42.98M -34.82M -32.63M -46.45M
EBIT
-28.52M -38M -39.39M -45.18M -51.93M -57.36M -58.29M -58.52M -60.01M -59.14M -62.3M -62.01M -44.53M -43.07M -34.92M -32.73M -46.55M
Depreciation & Amortization
618K 646K 611K 610K 608K 598K 472K 475K 475K 480K 366K 363K 362K 362K 95K 94K 96K